DE602009001116D1 - Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung - Google Patents

Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung

Info

Publication number
DE602009001116D1
DE602009001116D1 DE602009001116T DE602009001116T DE602009001116D1 DE 602009001116 D1 DE602009001116 D1 DE 602009001116D1 DE 602009001116 T DE602009001116 T DE 602009001116T DE 602009001116 T DE602009001116 T DE 602009001116T DE 602009001116 D1 DE602009001116 D1 DE 602009001116D1
Authority
DE
Germany
Prior art keywords
cell carcinoma
oral squamous
carcinoma
suppression
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602009001116T
Other languages
English (en)
Inventor
Johji Inazawa
Ken-Ichi Kozaki
Issei Imoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Tokyo Medical and Dental University NUC
Original Assignee
Fujifilm Corp
Tokyo Medical and Dental University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp, Tokyo Medical and Dental University NUC filed Critical Fujifilm Corp
Publication of DE602009001116D1 publication Critical patent/DE602009001116D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602009001116T 2008-01-23 2009-01-23 Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung Active DE602009001116D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008012256A JP5116026B2 (ja) 2008-01-23 2008-01-23 癌の検出方法および癌抑制剤

Publications (1)

Publication Number Publication Date
DE602009001116D1 true DE602009001116D1 (de) 2011-06-09

Family

ID=40748687

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602009001116T Active DE602009001116D1 (de) 2008-01-23 2009-01-23 Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung

Country Status (5)

Country Link
US (2) US20090202624A1 (de)
EP (1) EP2088208B1 (de)
JP (1) JP5116026B2 (de)
AT (1) ATE507309T1 (de)
DE (1) DE602009001116D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8420800B2 (en) 2009-04-16 2013-04-16 Keio University Head-and-neck tumor proliferation inhibitor
EP2283846A1 (de) * 2009-08-12 2011-02-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. miRNA-Verbindungen zur Behandlung von Prostatakarzinomen
JP5812491B2 (ja) * 2009-10-01 2015-11-11 国立研究開発法人国立がん研究センター 腫瘍治療剤
WO2011067346A1 (en) * 2009-12-04 2011-06-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for determining the efficiency of a cancer treatment
JP5775517B2 (ja) 2010-07-08 2015-09-09 武田薬品工業株式会社 糖尿病の予防・治療剤
WO2012151736A1 (en) * 2011-05-06 2012-11-15 Zhongshan Hospital Fudan University Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma
WO2013038737A1 (ja) 2011-09-16 2013-03-21 北海道公立大学法人 札幌医科大学 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ
WO2013071502A1 (en) * 2011-11-17 2013-05-23 Genedia Biotech Co Ltd Mir-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes
US10174314B2 (en) * 2011-12-22 2019-01-08 Interna Technologies B.V. MiRNA for treating head and neck cancer
DK2963125T3 (da) 2013-02-15 2020-10-12 Univ Nat Corp Tokyo Medical & Dental Terapeutisk middel til behandling af en cancer, hvor NRF2 er stabiliseret
WO2017079571A1 (en) * 2015-11-05 2017-05-11 Arphion Diagnostics Process for the indentication of patients at risk for oscc
EP4276184A3 (de) * 2017-11-09 2023-12-27 Purmx Therapeutics, Inc. Pharmazeutische zusammensetzung enthaltend mirna-3140 zur behandlung von krebs
JP7390002B2 (ja) * 2017-12-13 2023-12-01 国立大学法人広島大学 頭頸部がんの検出を補助する方法
EP3976058A4 (de) * 2019-06-03 2023-07-19 Carmel-Haifa University Economic Corporation Ltd. Behandlung von kopf-hals-karzinom beim menschen
TW202122572A (zh) 2019-08-09 2021-06-16 日商宇部興產股份有限公司 胞外體的產生方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295604B1 (de) 2004-02-09 2015-04-08 Thomas Jefferson University Krebsdiagnose und Behandlung durch microRNA, die sich in der Nähe von Krebs-verbindenen Chromosom-Merkmale befinden
PL2302055T3 (pl) 2004-11-12 2015-02-27 Asuragen Inc Sposoby i kompozycje z wykorzystaniem miRNA oraz cząsteczek inhibitorowych miRNA
EP1969147B1 (de) * 2006-01-05 2014-07-30 The Ohio State University Research Foundation mikro-RNA-basierte verfahren zur Diagnose von Magenkrebs
CN102943108B (zh) * 2006-01-05 2014-05-21 俄亥俄州立大学研究基金会 用于肺癌的诊断、预后和治疗的基于微小rna的方法和组合物
WO2007126150A1 (ja) * 2006-04-27 2007-11-08 National University Corporation Nagoya University 癌の新規治療用組成物
EP2369017B8 (de) * 2006-07-13 2014-03-12 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von Krankheiten im Zusammenhang mit dem Dickdarm

Also Published As

Publication number Publication date
EP2088208B1 (de) 2011-04-27
US8183223B2 (en) 2012-05-22
JP5116026B2 (ja) 2013-01-09
JP2009171876A (ja) 2009-08-06
US20090202624A1 (en) 2009-08-13
US20110076768A1 (en) 2011-03-31
ATE507309T1 (de) 2011-05-15
EP2088208A1 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
DE602007002090D1 (de) Verfahren zur Erkennung von anaplastischem Schilddrüsenkrebs, und Verfahren zur seiner Unterdrückung
EP3971299A3 (de) Kolorektalkrebsdetektionskit oder -vorrichtung und detektionsverfahren
EP3967769A3 (de) Lungenkrebsnachweiskit oder -vorrichtung und nachweisverfahren
WO2015058008A3 (en) Enhanced nucleic acid identification and detection
BRPI0919882A8 (pt) Métodos para avaliar padrões de rna
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
ATE501280T1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
WO2011141908A3 (en) Fluids testing apparatus and methods of use
WO2010129019A3 (en) Real-time sequencing methods and systems
WO2011055916A3 (ko) 장암 진단을 위한 장암 특이적 메틸화 마커 유전자의 메틸화 검출방법
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
WO2012096545A3 (ko) 췌장암 암줄기세포 특성을 이용한 췌장암 신규 바이오마커 및 그의 용도
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
EP2547809A4 (de) Verfahren, sondensets und kits zur erkennung der zerstörung von tumorunterdrückergenen durch in-situ-fluoreszenz-hybridisierung
WO2011076908A3 (en) An improved computer-implemented method of geometric feature detection
EP2314680A4 (de) Verfahren zur amplifikation einer zielnukleinsäuresequenz, verfahren zum mutationsnachweis mit dem verfahren und reagentien zur verwendung in den verfahren
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
BR112015000911A2 (pt) iniciadores cooperativos, sondas e suas respectivas aplicações
EP2177905A4 (de) Auf mikroalgen basierende biosensoren zur erkennung von umweltschadstoffen
WO2015059487A3 (en) Detection of cleavage activity of an enzyme
DE602007000378D1 (de) Verfahren und Vorrichtung zur Überprüfung der Integrität eines Wartungszusammenhangs sowie Verfahren und Vorrichtung zum Einfügen eines Wartungsendpunktes
WO2013062261A3 (en) Newly identified colon cancer marker and diagnostic kit using the same
WO2012064978A3 (en) Compositions, methods, and kits for detecting and identifying mycobacteria